Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A. Burger, Thomas J. Kipps, Osnat Bairey et al.|New England Journal of Medicine|2015Cited by 1.6k
COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcomeDan Zhang, Jinsong Hu, Rui Guo et al.|medRxiv|2020Cited by 146
Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cellsMark E. Gurney, Michael O’Dwyer|Cytotherapy|2022Cited by 37